Health economics data show high impact of indirect costs from progressive glaucoma

NICE, France — Glaucoma demographics and health economics studies show high costs related to progressive glaucoma, the greatest of which are non-medical, indirect costs, a presenter here said.The glaucoma population is estimated to reach 80 million worldwide by 2020 — 11 million of whom will be at the stage of bilateral blindness, Frances Meier-Gibbons, MD, said at the 2014 European Glaucoma Society meeting.